Briefly, the reduced expression of SC miR-23b-3p and elevated expression of miR-146a-5p in serum exosomes of CRC patients (Figure 6A) may help to enhance the sensitivity to EGFR-targeted drugs in all patients without considering stage. Here, EGFR is linked to colorectal carcinoma.